Results 171 to 180 of about 4,942,192 (218)

Autoimmune Disease Risk With GLP-1RA, DPP-4i, and SGLT2i Treatment in Patients With Diabetes. [PDF]

open access: yesACR Open Rheumatol
Mahajan A   +5 more
europepmc   +1 more source

KCNQ1 rs163184 Variant Modulates Susceptibility to Classic and DPP-4 Inhibitor-Associated Bullous Pemphigoid. [PDF]

open access: yesInt J Dermatol
Agiannitopoulos K   +8 more
europepmc   +1 more source

Immunofluorescence of Autoimmune Bullous Diseases

open access: yesSurgical Pathology Clinics, 2017
Autoimmmune bullous diseases of skin and mucosa are uncommon, disabling, and potentially lethal diseases. For a quick and reliable diagnosis immunofluorescence is essential. This article describes two variants of immunofluorescence. The direct method uses a skin or mucosal biopsy of the patient to detect in vivo bound antibodies.
Gilles F, Diercks   +2 more
openaire   +3 more sources

Mucosal anomalies in autoimmune bullous diseases [PDF]

open access: yesNederlands Tijdschrift Voor Tandheelkunde, 2023
Mucosal anomalies are frequently seen in autoimmune bullous diseases, particularly in pemphigus vulgaris and mucous membrane pemphigoid. The blistering, erosions, ulceration or erythema may present anywhere on the oral mucosa, but also on other mucosal sites.
J M, Meijer, A, Vissink
openaire   +3 more sources

Home - About - Disclaimer - Privacy